NYSE:MDTMedical Equipment
Assessing Medtronic’s Valuation After Strong Q3 2026 Results And Dividend Aristocrat Reaffirmation
Medtronic (MDT) is back in focus after reporting better-than-expected Q3 2026 results, highlighting 6% organic revenue growth and affirming a quarterly dividend of $0.71 per share that extends its dividend aristocrat record.
See our latest analysis for Medtronic.
Despite the Q3 beat, Medtronic’s recent share price performance has been weak, with a 30 day share price return of 13.84% and a year to date share price return of 9.03%. The 3 year total shareholder return of 21.56% contrasts with a...